Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen - No Study Results Posted

Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen (PAPRIKA)

This study is ongoing, but not recruiting participants.

Study NCT00417209 Information provided by Sanofi-Aventis

First Received: December 28, 2006 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)